Introduction
Zimiplan 40 Tablet by Astemax Biotech contains 40 mg pantoprazole in a gastro-resistant formulation, delivering reliable acid suppression for GERD and ulcer treatment. This high-quality tablet ensures targeted release in the intestine, produced in WHO-GMP certified facilities for consistent efficacy.
Tablet Composition
Zimiplan 40 features pantoprazole 40 mg as gastro-resistant tablets that protect the active ingredient from stomach acid degradation. This design allows precise delivery to parietal cells for optimal proton pump inhibition. Packaged in convenient 10s strips for easy dispensing.
Main Benefits
-
Effectively treats heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome by blocking acid production.
-
Promotes healing of erosive esophagitis while preventing symptom recurrence.
-
Once-daily convenience with 24-hour acid control for better patient adherence.
Quality Standards
Astemax Biotech manufactures Zimiplan 40 in WHO-GMP certified plants, maintaining strict purity, stability, and bioavailability controls. Ethical promotion focuses on proven clinical results.